Drugs / BLI850
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00756548 | Aug → Nov 2008 | colon carcinoma | Braintree Laboratories | Completed | No outcome recorded |
| Phase 3 | NCT00756977 | Aug → Nov 2008 | colon carcinoma | Braintree Laboratories | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLI850 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00756977 ↗ |
| Route | Oral | “multi-dose preparation for oral administration prior to colonoscopy” NCT00756548 ↗ |